Every tenth child is overweight, every twentieth even obese. Scientists at the Berlin Institute of Health (BIH), together with colleagues at Charité and the Helmholtz Centre for Environmental Research (UFZ) in Leipzig, have now studied a relationship…

Bispecific Antibody for Cancer Treatment Optimized by GlymaxX® Technology

“Multinational research projects on Personalised Medicine for Neurodegenerative Diseases”

More than €10 million in funding awarded to Charité

The research partnership between the University of Oxford and the four Berlin partners – Freie Universität Berlin, Humboldt-Universität zu Berlin, Technische Universität Berlin, and Charité – Universitätsmedizin Berlin – is picking up speed: all five…

Findings include stable disease and prolonged time on treatment vs. prior therapy in heavily pretreated metastatic pancreatic and colorectal cancer patients

The fatty acid propionate helps defend against the effects of high blood pressure, including atherosclerosis and heart tissue remodeling, a study on mice has found. Gut bacteria produce the substance – which calms the immune cells that drive up blood…

How does a normal cell turn into a deadly cancer? Seeking an answer to this question, and working alongside other international working groups, researchers from Charité – Universitätsmedizin Berlin examined the tumor genomes of nearly 300 prostate…

Implementing a project entitled ‘BrainPlay’, an interdisciplinary team of researchers will explore the way in which play affects the human brain. Researchers from Charité – Universitätsmedizin Berlin and the Berlin Institute of Health (BIH),…

The CRISPR-Cas9 gene editing system has been generating excitement within the field of gene therapy, inspiring hopes of molecular tools capable of treating genetic diseases. By studying immune responses to CRISPR-Cas9 in humans, researchers from…